Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prapchompoothaweep is a traditional Thai polyherbal remedy included in the Thai National List of Essential Medicines (NLEM). It is primarily indicated for the treatment of allergic rhinitis and symptoms of the common cold. The formulation is a complex mixture of over 20 herbal ingredients, including *Piper nigrum* (black pepper), *Zingiber officinale* (ginger), and *Piper retrofractum*. It is traditionally classified as a warming remedy in Thai medicine. Clinical research, including Phase II trials conducted by Thammasat University, has evaluated its efficacy and safety compared to standard antihistamines like loratadine, demonstrating its potential to reduce nasal symptoms through anti-inflammatory and anti-allergic mechanisms, likely involving the modulation of inflammatory mediators.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Prapchompoothaweep.